Background Initial randomised controlled trials (RCTs) showed that prophylactic
azithromycin in pregnant women improved maternal and neonatal outcomes; however, the …

1. Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a
review. JAMA. 2023; 329 (7): 574-587. doi: 10.1001/jama. 2023.0023 2. Stern A, Green H …

Importance Repeated mass distribution of azithromycin has been shown to reduce
childhood mortality by 14% in sub-Saharan Africa. However, the estimated effect varied by …

Background Neonatal sepsis is a deadly disease with non-specific clinical signs, delaying
diagnosis and treatment. There remains a need for early biomarkers to facilitate timely …

Background Rectovaginal colonization with Group B Streptococcus during pregnancy has
historically been shown to be associated with an increased risk of clinical chorioamnionitis …

Objectives A systematic review with met‐analysis was performed to summarise the evidence
on the effect of intrapartum azithromycin on maternal and neonatal infections and deaths …

Background Limited data exist on the effects of intrapartum azithromycin on the prevalence
of carriage and antibiotic resistance of Enterobacterales. Methods We conducted a …

1. Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a
review. JAMA. 2023; 329 (7): 574-587. doi: 10.1001/jama. 2023.0023 2. Stern A, Green H …

Aim To develop evidence‐based clinical algorithms for the assessment and management of
spontaneous, uncomplicated labour and vaginal birth. Population Pregnant women at any …

Intrapartum azithromycin prophylaxis has shown the potential to reduce maternal infections
but showed no effect on neonatal sepsis and mortality. Antibiotic exposure early in life may …